China now offers a dizzyingly abundant source of innovative, high-quality therapies at—by pharma standards—reasonable prices.

RFK Jr. is attempting to curb pharma ad spending, according to Bloomberg. One expert and former senior HHS official thinks ...

Given that the Australian government heavily subsidizes pharmaceuticals— spending more than $AU16.7 billion annually through ...

The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to ...

Andre Fernando, president of the Sri Lanka-Bangladesh Business Cooperation Council, urged Bangladeshi entrepreneurs to invest in and contribute to the development of Sri Lanka's pharmaceutical sector ...

India's pharmaceutical industry is experiencing relief as active pharmaceutical ingredient (API) prices plummet due to ...

Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, ...

Pharmaceutical laboratories and life-science manufacturers sit on a goldmine of intellectual property and patient data.

Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He’s long wanted to ...

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

Despite strong and welcome progress being made, the Polish pharma sector still hesitates on medical innovation competition ...

The task was to be carried out by health secretary Robert F. Kennedy Jr., according to an executive order released by ...